Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?
Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?
复制标题
DOI:
10.7150/thno.7193
复制
发表时间:
2013-12-11
期刊:
影响因子:
12.4
通讯作者:
Choyke PL
中科院分区:
文献类型:
--
作者:
Kobayashi H;Watanabe R;Choyke PL
Nano-sized therapeutic agents have several advantages over low molecular weight agents such as a larger loading capacity, the ability to protect the payload until delivery, more specific targeting due to multivalency and the opportunity for controlled/sustained release. However, the delivery of nano-sized agents into cancer tissue is problematic because it mostly relies on the enhanced permeability and retention (EPR) effect that depends on the leaky nature of the tumor vasculature and the prolonged circulation of nano-sized agents, allowing slow but uneven accumulation in the tumor bed. Delivery of nano-sized agents is dependent on several factors that influence the EPR effect; 1. Regional blood flow to the tumor, 2. Permeability of the tumor vasculature, 3. Structural barriers imposed by perivascular tumor cells and extracellular matrix, 4. Intratumoral pressure. In this review, these factors will be described and methods to enhance nano-agent delivery will be reviewed.
登录
查看更多内容
影响因子:
17.4
作者:
Gormley AJ;Larson N;Sadekar S;Robinson R;Ray A;Ghandehari H
通讯作者:
Ghandehari H
DOI:
10.1002/wnan.40
发表时间:
2009-07
影响因子:
8.6
作者:
Canelas, Dorian A.;Herlihy, Kevin P.;DeSimone, Joseph M.
通讯作者:
DeSimone, Joseph M.
影响因子:
5.7
作者:
Fang, Jun;Qin, Haibo;Maeda, Hiroshi
通讯作者:
Maeda, Hiroshi
影响因子:
3.3
作者:
Cyran, Clemens C.;Sennino, Barbara;Fu, Yanjun;Rogut, Victor;Shames, David M.;Chaopathomkul, Bundit;Wendland, Michael F.;McDonald, Donald M.;Brasch, Robert C.;Raatschen, Hans-Juergen
通讯作者:
Raatschen, Hans-Juergen
影响因子:
78.8
作者:
Jain, Rakesh K.;Stylianopoulos, Triantafyllos
通讯作者:
Stylianopoulos, Triantafyllos